Study ID: TVP - 1012/233
Study Title
- Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease
Teva Identifier
- TVP - 1012/233
ClinicalTrials.gov Identifier
- NCT00203138
Study Status
- Completed
Trial Condition(s)
- Parkinson's Disease
Interventions
- Drug: rasagiline mesylate
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 35 Years and older
Trial Duration
- 06/01/2004 - 12/01/2006
Phase
- Phase 3
Study Type
Interventional